Gary Jacob, EC, Director at Synergy Pharmaceuticals Inc, holds 12.50K shares in OKYO Pharma Limited Sponsored ADR (Ticker: OKYO), holds 21.92K shares in Cardiff Oncology (Ticker: CRDF), holds 3.50K shares in Virpax Pharmaceuticals (Ticker: VRPX). Most recently, Gary Jacob Bought ― shares of OKYO Pharma Limited Sponsored ADR on May 19, 2022 for an estimated value of 50.00K.
What is the percentage of profitable transactions made by Gary Jacob?
The percentage of profitable transactions made by Gary Jacob is 13%.
What is the average return per transaction made by Gary Jacob?
The average return per transaction made by Gary Jacob is 4.60%.
What stocks does Gary Jacob hold?
Gary Jacob holds: SGYPQ, HEPA, VRPX, OKYO, CRDF stocks.
What was Gary Jacob’s latest transaction?
Gary Jacob latest transaction was an Informative Buy of $50.00K.
What was Gary Jacob's most profitable transaction?
Gary Jacob’s most profitable transaction was an Informative Buy of CRDF stock on May 18, 2020. The return on the trade was 371.00%.
What is Gary Jacob's role in Synergy Pharmaceuticals Inc?
Gary Jacob's role in Synergy Pharmaceuticals Inc is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.